Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin Administration With 5-HT1a Blockade
NCT07565493Phase 1Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Aug 2026
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Psilocybin + Placebo with Psilocybin + Pindolol (2 arms). Primary endpoint: Mystical Experiences Questionnaire at 10 days. Started Aug 2026; status: recruiting.
02
Drugs
pindololpsilocybin
Beyond the preview
Go deeper on NCT07565493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07565493.